Hypercholesterolemia represents a leading cause in the development of atherosclerotic
plaques, increasing the risk for ACVS. It actually counts as a major cause of cardiovascular …

ABSTRACT Introduction: 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase
inhibitors (statins) are widely used for cardiovascular disease (CVD) prevention. Long-term …

In humans, aging, triggers increased plasma concentrations of triglycerides, cholesterol, low-
density lipoproteins and lower capacity of high-density lipoproteins to remove cellular …

Malnutrition is a serious and prevalent health problem in the older population, and
especially in hospitalised or institutionalised subjects. Accurate and early risk detection is …

Age is associated with increased cardiovascular risk factors and cardiovascular disease,
which constitutes the leading cause of morbidity and mortality in elderly population. In this …

LDL cholesterol, or low-density lipoprotein cholesterol, is a fat that circulates in the blood,
moving cholesterol around the body to where it is needed for cell repair and depositing it …

hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors are ubiquitously prescribed for
cardiovascular disease (CVD) prevention and treatment. However, the use of statins has …

Introduction While atherosclerotic cardiovascular disease is affecting growing numbers of
patients, lipid-lowering therapies have been continuously improving to achieve prevention of …

Background: Since older patients with dyslipidemia frequently receive many prescriptions,
medication errors are typical and expected in this population. This risk has increased by …

Objetivo: Conocer el comportamiento epidemiológico y asociaciones de la FA en población
mexicana. Material y métodos: Analizamos 8,686 pacientes de 38 cardiólogos inscritos en …